Bannaga Ayman, Kelman Lawrence, O'Connor Michelle, Pitchford Claire, Walters Julian R F, Arasaradnam Ramesh P
Department of Gastroenterology , University Hospital Coventry and Warwickshire , Coventry , UK.
BAM Facebook Group , Coventry , UK.
BMJ Open Gastroenterol. 2017 Jan 19;4(1):e000116. doi: 10.1136/bmjgast-2016-000116. eCollection 2017.
Bile acid diarrhoea (BAD) is an underdiagnosed condition producing diarrhoea, urgency and fear of faecal incontinence. How patients experience these symptoms has not previously been studied. Bile Acid Malabsorption (BAM) Support UK was established in 2015 as a national charity with objectives including to provide details regarding how BAD affects patients, to improve earlier recognition and clinical management.
A questionnaire was collected anonymously by BAM Support UK and the Bile Salt Malabsorption Facebook group over 4 weeks at the end of 2015. It comprised 56 questions and aimed to inform patients and clinicians about how BAD affects the respondents.
The first 100 responses were analysed. 91% of the respondents reported a diagnosis of BAD. 58% of total respondents diagnosed following a Selenium-homocholic acid taurine scan, 69% were diagnosed by a gastroenterologist, with type 2 and 3 BAD comprising 38% and 37%, respectively, of total respondents. Symptoms had been experienced for more than 5 years before diagnosis in 44% of respondents. Following treatment, usually with bile acid sequestrants, 60% of participants reported improvement of diarrhoea and most reported their mental health has been positively impacted. Just over half of the cohort felt as though their symptoms had been dismissed during clinical consultations and 28% felt their GPs were unaware of BAD.
BAD requires more recognition by clinicians to address the current delays in diagnosis. Treatment improves physical and mental symptoms in the majority of participants.
胆汁酸腹泻(BAD)是一种诊断不足的疾病,可导致腹泻、急迫感和对大便失禁的恐惧。此前尚未研究过患者如何体验这些症状。英国胆汁酸吸收不良(BAM)支持组织于2015年成立,作为一个全国性慈善机构,其目标包括提供有关BAD如何影响患者的详细信息,以提高早期识别和临床管理水平。
设计、背景和主要结果:2015年底,英国BAM支持组织和胆汁盐吸收不良脸书小组在4周内匿名收集了一份问卷。该问卷包含56个问题,旨在让患者和临床医生了解BAD如何影响受访者。
对前100份回复进行了分析。91%的受访者报告被诊断为BAD。在所有受访者中,58%在进行硒-高牛磺酸胆酸扫描后被诊断出来,69%由胃肠病学家诊断,其中2型和3型BAD分别占受访者总数的38%和37%。44%的受访者在确诊前症状已持续超过5年。在接受通常使用胆汁酸螯合剂的治疗后,60%的参与者报告腹泻有所改善,大多数人表示他们的心理健康受到了积极影响。略超过一半的队列认为他们的症状在临床咨询中被忽视,28%的人觉得他们的全科医生不了解BAD。
临床医生需要更多地认识到BAD,以解决当前诊断延迟的问题。治疗可改善大多数参与者的身心症状。